As a leading expert in biopharma innovation, Ivan Kairatov has dedicated his career to the intersection of technology and medicine. His work focuses on pioneering new frontiers in research and development, particularly in creating intelligent therapeutic systems. Today, he shares his insights on a
The landscape of intraoperative imaging is undergoing a profound transformation, steering the conversation away from a singular pursuit of maximum image resolution toward a more nuanced and safety-conscious paradigm. This evolution is most apparent in orthopedics, where the increasing
A landmark study examining mental health care delivery for millions of Medicare beneficiaries has revealed that telehealth, once a temporary measure, has firmly established itself as a dominant and permanent fixture in the healthcare landscape, fundamentally reshaping how patients access services
Sevoflurane has long been a cornerstone of pediatric anesthesia, allowing millions of children to undergo necessary surgical procedures safely and without pain each year. Despite its widespread and effective use, a shadow of concern has emerged from preclinical research, where animal studies have
The continued access to virtual medical care for millions of American seniors hangs precariously in the balance, subject to a legislative cycle of temporary extensions that introduces profound instability into the nation's healthcare system. Responding to this critical uncertainty, the American
The 44 new drugs that gained approval from the FDA's Center for Drug Evaluation and Research in 2025 represented far more than a simple numerical milestone; they collectively heralded a fundamental paradigm shift in the landscape of therapeutic development. This pivotal year was defined not by the
